Elanco Animal Health Incorporated (ELAN) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Greenfield, IN, アメリカ. 現CEOは Jeffrey N. Simmons.
ELAN を有する IPO日 2018-09-20, 9,000 名の正社員, に上場 NYSE, 時価総額 $11.99B.
Elanco Animal Health Incorporated is a global animal health company that innovates, develops, manufactures, and markets pharmaceutical and nutritional products for both companion animals and farm animals. For pets, the company offers disease prevention products such as parasiticides and vaccines under brands including Seresto, Advantage, and Advantix, as well as therapeutic treatments for pain, osteoarthritis, and dermatological conditions. In the farm animal sector, Elanco provides vaccines, antibiotics, parasiticides, and nutritional health products for poultry, aquaculture, ruminant, and swine production, with key brands including Rumensin and Baytril. The company distributes its products through veterinarians, third-party distributors, and direct relationships with farm animal producers. Founded in 1954 and headquartered in Greenfield, Indiana, Elanco serves a diverse customer base spanning veterinary clinics and agricultural operations worldwide.
